Kikuchi-Fujimoto disease presenting in a patient with SARS-CoV-2: a case report

Samuel D. Racette*, Borislav A. Alexiev, Michael P. Angarone, Ajay Bhasin, Kaitlin Lima, Lawrence J. Jennings, Senthil Balasubramanian, Akihiro J. Matsuoka

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

7 Scopus citations


Background: We present a yet to be described association of SARS-CoV-2 infection with Kikuchi-Fujimoto disease. Case presentation: A 32-year-old physician with history of SARS-CoV-2 infection presented to the emergency department with 2 weeks of fever, chills, and right sided cervical lymphadenopathy. He was treated empirically for presumed folliculitis with worsening of symptoms leading to repeat presentation to the emergency department. Extensive workup was unrevealing of an infectious cause and needle biopsy of the lesion was unrevealing. An excisional lymph node biopsy revealed follicular hyperplasia with necrotic foci showing abundance of histiocytes at the edge of necrosis with CD8 predominance of T-cells. Final diagnosis was deemed to be Kikuchi-Fujimoto disease. Antibiotic therapy was discontinued, and the patient’s symptoms resolved with steroid therapy and expectant management. Conclusions: This is the first report of a patient developing Kikuchi-Fujimoto disease following SARS-CoV-2 infection. Clinicians should be aware of Kikuchi-Fujimoto disease as a possibility when approaching patients with hyper-inflammatory states who present with cervical lymphadenopathy.

Original languageEnglish (US)
Article number740
JournalBMC Infectious Diseases
Issue number1
StatePublished - Dec 2021


  • COVID-19
  • Cervical lymphadenopathy
  • Kikuchi-Fujimoto Syndrome
  • SARS-CoV-2

ASJC Scopus subject areas

  • Infectious Diseases


Dive into the research topics of 'Kikuchi-Fujimoto disease presenting in a patient with SARS-CoV-2: a case report'. Together they form a unique fingerprint.

Cite this